Cite
HARVARD Citation
Badar, T. et al. (2022). Outcomes of TP53‐mutated AML with evolving frontline therapies: Impact of allogeneic stem cell transplantation on survival. American journal of hematology. 97 (7), pp. E232-E235. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Badar, T. et al. (2022). Outcomes of TP53‐mutated AML with evolving frontline therapies: Impact of allogeneic stem cell transplantation on survival. American journal of hematology. 97 (7), pp. E232-E235. [Online].